TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes
|
|
- Violet Fields
- 5 years ago
- Views:
Transcription
1 30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted. Notification of Product Changes (NOPC) forms and Pharmacodes Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12 th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12 th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode. 2013/14 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017 Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule CORRECTION to May 2014 tender notification: in bold and strikethrough 1. Tenders awarded to listed pharmaceuticals where only the current brand is listed. Fluconazole cap 200 mg; 28 capsule, blister pack pack price $13.34 New pack price $9.70 $9.69 Hospital Supply Ozole DV Limit Date of price change Hospital Supply Status date 1% 1 September November 2014 A qa25123 Page 1 of 17
2 2012/13 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2016 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 2. Tenders awarded to pharmaceuticals where at least one other brand is listed. subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Tenoxicam tab 20 mg; 20 tablet, blister pack $23.75 per 100 $3.05 per 20 Reutenox (ABM) 1 November January April 2015 Tilcotil (Valeant) Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 3. Tenders awarded to pharmaceuticals where at least one other brand is listed. Tenoxicam tab 20 mg; 20 tablet, blister pack pack price $23.75 per 100 New pack price $3.05 per 20 Hospital Supply Reutenox (ABM) DV Limit Date of listing/price change for tender winning brand Hospital Supply Status date (and delisting of other listed brands) 1% 1 November January 2015 to be delisted Tilcotil (Valeant) A qa25123 Page 2 of 17
3 2013/14 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 4. Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed. subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Cetirizine oral liq 1 mg per ml; 200 ml, bottle $3.52 $2.99 Histaclear (AFT) 1 December February May 2015 Cetirizine AFT (AFT) Glycerol Liquid; 500 ml, bottle $ per 2,000 ml $3.71- per 500 ml healthe Glycerol BP (Jaychem) 1 October December March 2015 healthe Glycerol BP- 2,000 ml pack size (Jaychem) Losartan potassium tab 12.5 mg; 84 tablet blister pack $2.88 per 90 $1.55 per 84 tablet Losartan Actavis 1 November January April 2015 Lostaar Losartan potassium tab 25 mg; 84 tablet blister pack $3.20 per 90 $1.90 per 84 tablet Losartan Actavis 1 November January April 2015 Lostaar Losartan potassium tab 50 mg; 84 tablet blister pack $5.22 per 90 $2.25 per 84 tablet Losartan Actavis 1 November January April 2015 Lostaar Losartan potassium tab 100 mg; 84 tablet blister pack $8.68 per 90 $2.60 per 84 tablet Losartan Actavis 1 November January April 2015 Lostaar Magnesium sulphate inj 2 mmol per ml, 5 ml 10 ampoules $26.60 $12.65 DBL 1 August October January 2015 Martindale (Max Health) Perindopril tab 2 mg; 30 tablet blister pack $3.75 $3.75 Apo-Perindopril 1 August October January 2015 Coversyl (Servier) Perindopril tab 4 mg; 30 tablet blister pack $4.80 $4.80 Apo-Perindopril 1 August October January 2015 Coversyl (Servier) A qa25123 Page 3 of 17
4 subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Tar with triethanolamine lauryl sulphate and fluorescein soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium; 500 ml, bottle $3.05 per 500 ml $3.36 per 500 ml Pinetarsol 1 October 2014 n/a 1 March 2014 Pinetarsol (1,000 ml pack size) 5. Tenders awarded to currently listed pharmaceuticals where no other brand is listed. Chemical name subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date Abacavir sulphate tab 300 mg; 60 tablet, blister pack $ $ Ziagen (GSK) Abacavir sulphate oral liq 20 mg per ml, 240 ml OP, bottle $50.00 $ Ziagen (GSK) Amantadine cap 100 mg; 60 tablet, bottle $ Symmetrel Aminophylline inj 25 mg per ml, 10 ml $53.75 $ DBL Aminophylline Calcitonin inj 100 iu per ml, 1 ml $ $ Miacalcic Calcium folinate inj 50 mg; $24.50 $18.25 Calcium Folinate Ebewe Dexamethasone eye drops 0.1 %; 5 ml OP, dropper bottle $4.50 $4.50 Maxidex Dexamethasone eye oint 0.1%; 3.5 g OP, tube $5.86 $5.86 Maxidex A qa25123 Page 4 of 17
5 Chemical name subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date inj 25 mg per ml, 3 ml $12.00 $13.20 suppos 12.5 mg; 10 suppositories, blister pack $1.85 $2.04 suppos 25 mg; 10 suppositories, blister pack $2.22 $2.44 suppos 50 mg; 10 suppositories, blister pack $3.84 $4.22 suppos 100 mg; 10 suppositories, blister pack $6.36 $7.00 Ergometrine maleate inj 500 mcg per ml, 1 ml $31.00 $94.70 DBL Ergometrine Glucose [Dextrose] inj 50%, 10 ml $19.50 $27.50 Biomed (Biomed) Glucose [Dextrose] inj 50%, 90 ml bottle; 1 bottle $11.25 $14.50 Biomed (Biomed) Hydrocortisone powder; 25 g $44.00 $59.50 ABM (ABM) 1 October January 2015 Hydrocortisone with wool fat and mineral oil lotn 1% with wool fat hydrous 3% and mineral oil; 250 ml, bottle $9.95 $10.57 DP Lotn HC 1 October January 2015 Ketoconazole shampoo 2%; 100 ml OP, bottle $3.08 $2.99 Sebizole 1 October January 2015 Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride powder for oral soln g with potassium chloride 46.6 mg, sodium bicarbonate mg and sodium chloride mg; 30 sachets $10.00 $7.65 Lax-Sachets (AFT) A qa25123 Page 5 of 17
6 Chemical name subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date Methotrexate inj 100 mg per ml, 50 ml vial; 1 vial $ $99.99 Methotrexate Ebewe Miconazole nitrate crm 2%; 15 g OP, tube $0.46 $0.55 Multichem (Multichem) 1 January April 2015 Miconazole nitrate vaginal crm 2% with applicator; 40 g OP, tube $2.75 ($4.10) $3.95 Micreme inj 5 mg per ml, 1 ml $5.51 $12.48 DBL Morphine Sulphate inj 10 mg per ml, 1 ml $4.79 $9.09 DBL Morphine Sulphate inj 15 mg per ml, 1 ml $5.01 $9.77 DBL Morphine Sulphate inj 30 mg per ml, 1 ml $5.30 $12.43 DBL Morphine Sulphate Nicotinic acid tab 50 mg; 100 tablet, blister pack $4.17 $3.96 Apo-Nicotinic Acid Nicotinic acid tab 500 mg; 100 tablet, blister pack $16.54 $17.37 Apo-Nicotinic Acid Nitrazepam tab 5 mg; 100 tablet, bottle pack $4.98 $5.22 Nitrados 1 October January 2015 Ondansetron tab disp 4 mg; 10 tablet, blister pack $1.70 $1.00 Dr Reddy s Ondansetron (Dr Reddy s) Ondansetron tab disp 8 mg; 10 tablet, blister pack $2.00 $1.50 Ondansetron ODT-DRLA (Dr Reddy s) Oxazepam tab 10 mg; 100 tablet, blister pack $5.89 $6.17 Ox-Pam 1 October January 2015 Oxazepam tab 15 mg; 100 tablet, blister pack $8.13 $8.53 Ox-Pam 1 October January 2015 A qa25123 Page 6 of 17
7 Chemical name subsidy and (price) New subsidy and price Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date Pyridoxine tab 25 mg; 90 tablet, bottle $2.20 $2.10 PyridoxADE (BNM) 1 November February 2015 Pyridoxine tab 50 mg; 500 tablet, bottle $12.16 $11.55 Apo-Pyridoxine cap 50 mg; 100 capsule, blister pack $4.95 $2.50 Arrow- tab sustained-release 100 mg; 20 tablet, blister pack $2.14 $2.00 Tramal SR 100 (biocsl) tab sustained-release 150 mg; 20 tablet, blister pack $3.21 $3.00 Tramal SR 150 (biocsl) tab sustained-release 200 mg; 20 tablet, blister pack $4.28 $4.00 Tramal SR 200 (biocsl) Tropicamide eye drops 0.5%; 15 ml OP, dropper bottle $7.15 $7.15 Mydriacyl Tropicamide eye drops 1%; 15 ml OP, dropper bottle $8.66 $8.66 Mydriacyl Vancomycin inj 500 mg; 1 vial $3.58 $2.64 Mylan 6. Tenders awarded to pharmaceuticals where no brand is listed. Pack price Hospital Supply Listing date Sole Subsidised Supply date *Rifaximin tab 550 mg; 56 tablet, blister pack $ Xifaxan (Norgine) *Listing will be subject to Specialy Authority restrictions which will be outlined in the Pharmacetuical Schedule and a separate notification A qa25123 Page 7 of 17
8 Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 7. Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed. pack price New pack price Hospital Supply DV Limit Date of listing/price change for tender winning brand Hospital Supply Status date (and delisting of other listed brands) to be delisted Cetirizine oral liq 1 mg per ml; 200 ml, bottle $3.52 $2.99 Histaclear (AFT) 1% 1 December February 2015 Cetirizine AFT (AFT) Losartan potassium tab 12.5 mg; 84 tablet blister pack $2.88 per 90 $1.55 per 84 tablet Losartan Actavis 1% 1 November January 2015 Lostaar Losartan potassium tab 25 mg; 84 tablet blister pack $3.20 per 90 $1.90 per 84 tablet Losartan Actavis 1% 1 November January 2015 Lostaar Losartan potassium tab 50 mg; 84 tablet blister pack $5.22 per 90 $2.25 per 84 tablet Losartan Actavis 1% 1 November January 2015 Lostaar Losartan potassium tab 100 mg; 84 tablet blister pack $8.68 per 90 $2.60 per 84 tablet Losartan Actavis 1% 1 November January 2015 Lostaar Magnesium sulphate inj 2 mmol per ml, 5 ml 10 ampoules $18.35 $12.65 DBL Martindale (Max Health) Meropenem inj 500 mg vial; 10 vials $10.50 per 1 vial $35.22 per 10 vials DBL Meropenem Penembact (Interpharma) Meropenem inj 1 g vial; 10 vials $21.00 per 1 vial $65.21 per 10 vials DBL Meropenem Penembact (Interpharma) Perindopril tab 2 mg; 30 tablet blister pack $3.75 $3.75 Apo-Perindopril Coversyl (Servier) Perindopril tab 4 mg; 30 tablet blister pack $4.80 $4.80 Apo-Perindopril Coversyl (Servier) 8. Tenders awarded to listed pharmaceuticals where only the current brand is listed. pack price New pack price Hospital Supply DV Limit Date of price change Hospital Supply Status date A qa25123 Page 8 of 17
9 Abacavir sulphate tab 300 mg; 60 tablet, blister pack $ $ Ziagen (GSK) Abacavir sulphate oral liq 20 mg per ml, 240 ml, bottle $50.00 $ Ziagen (GSK) Amantadine cap 100 mg; 60 tablet, bottle $ Symmetrel Aminophylline inj 25 mg per ml, 10 ml $53.75 $ DBL Aminophylline Calcitonin inj 100 iu per ml, 1 ml $ $ Miacalcic Calcium folinate 1 inj 10 mg per ml, 5 ml $24.50 $18.25 Calcium Folinate Ebewe Calcium folinate 1 inj 10 mg per ml, 10 ml vial; 1 vial $9.75 $7.33 Calcium Folinate Ebewe Calcium folinate 1 inj 10 mg per ml, 30 ml vial; 1 vial $30.00 $22.51 Calcium Folinate Ebewe Calcium folinate 1 inj 10 mg per ml, 100 ml vial; 1 vial $90.00 $67.51 Calcium Folinate Ebewe Cefotaxime inj 1 g vial; 10 vials $15.58 $17.10 DBL Dexamethasone eye drops 0.1 %; 5 ml, dropper bottle $4.50 $4.50 Maxidex Dexamethasone eye oint 0.1%; 3.5 g, tube $5.86 $5.86 Maxidex inj 25 mg per ml, 3 ml $12.00 $13.20 A qa25123 Page 9 of 17
10 suppos 12.5 mg; 10 suppositories, blister pack $1.85 $2.04 suppos 25 mg; 10 suppositories, blister pack $2.22 $2.44 suppos 50 mg; 10 suppositories, blister pack $3.84 $4.22 suppos 100 mg; 10 suppositories, blister pack $6.36 $7.00 Ergometrine maleate inj 500 mcg per ml, 1 ml $31.00 $94.70 DBL Ergometrine Gemcitabine 2 inj 10 mg per ml, 20 ml vial; 1 vial $12.50 $8.36 Gemcitabine Ebewe Gemcitabine 2 inj 10 mg per ml, 100 ml vial; 1 vial $62.50 $15.89 Gemcitabine Ebewe Glucose [Dextrose] inj 50%, 10 ml $19.50 $27.50 Biomed (Biomed) Glucose [Dextrose] inj 50%, 90 ml bottle; 1 bottle $11.25 $14.50 Biomed (Biomed) Hydrocortisone Powder; 25 g $44.00 $59.50 ABM (ABM) 1% 1 October December 2014 Ketoconazole shampoo 2%; 100 ml, bottle $3.08 $2.99 Sebizole 1% 1 October December 2014 Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride powder for oral soln g with potassium chloride 46.6 mg, sodium bicarbonate mg and sodium chloride mg; 30 sachets $10.00 $7.65 Lax-Sachets (AFT) A qa25123 Page 10 of 17
11 Methotrexate 3 inj 100 mg per ml, 50 ml vial; 1 vial $ $99.99 Methotrexate Ebewe Miconazole nitrate crm 2%; 15 g, tube $0.46 $0.55 Multichem (Multichem) 1% 1 January March 2015 inj 1 mg per ml, 10 ml syringe $39.50 $45.00 Biomed (Biomed) inj 1 mg per ml, 50 ml syringe $79.50 $87.50 Biomed (Biomed) inj 1 mg per ml, 100 ml bag $ $ Biomed (Biomed) inj 5 mg per ml, 1 ml $5.51 $12.48 DBL Morphine Sulphate inj 10 mg per ml, 1 ml $4.79 $9.09 DBL Morphine Sulphate inj 15 mg per ml, 1 ml $5.01 $9.77 DBL Morphine Sulphate inj 30 mg per ml, 1 ml $5.30 $12.43 DBL Morphine Sulphate Ondansetron tab disp 4 mg; 10 tablet, blister pack $1.70 $1.00 Dr Reddy s Ondansetron (Dr Reddy s) Ondansetron tab disp 8 mg; 10 tablet, blister pack $2.00 $1.50 Ondansetron ODT- DRLA (Dr Reddy s) Pyridoxine tab 25 mg; 90 tablet, bottle $2.20 $2.10 PyridoxADE (BNM) 1% 1 November January 2015 Pyridoxine tab 50 mg; 500 tablet, bottle $12.16 $11.55 Apo-Pyridoxine cap 50 mg; 100 capsule, blister pack $4.95 $2.50 Arrow- A qa25123 Page 11 of 17
12 inj 50 mg per ml, 1 ml ampoule $4.50 $4.50 Tramal 50 (biocsl) inj 50 mg per ml, 2 ml ampoule $4.50 $4.50 Tramal 100 (biocsl) tab sustained-release 100 mg; 20 tablet, blister pack $2.14 $2.00 Tramal SR 100 (biocsl) tab sustained-release 150 mg; 20 tablet, blister pack $3.21 $3.00 Tramal SR 150 (biocsl) tab sustained-release 200 mg; 20 tablet, blister pack $ 4.28 $4.00 Tramal SR 200 (biocsl) Tropicamide eye drops 0.5%; 15 ml, dropper bottle $7.15 $7.15 Mydriacyl Tropicamide eye drops 1%; 15 ml, dropper bottle $8.66 $8.66 Mydriacyl Vancomycin inj 500 mg; 1 vial $3.58 $2.64 Mylan 1. The price and subsidy of calcium folinate (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 August The subsidy for calcium folinate inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.10 per 1 mg to $0.06 per 1 mg from 1 August The price and subsidy of gemcitabine (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 August The subsidy for gemcitabine inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.07 per 1 mg to $0.02 per 1 mg from 1 August The price and subsidy of methotrexate (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 August The subsidy for methotrexate inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will not change from $0.10 per 1 mg 9. Tenders awarded to pharmaceuticals where no brand is listed. Pack price Hospital Supply DV Limit Listing date Hospital Supply Status date Amikacin inj 250 mg per ml, 2 ml vial; 5 vials $ DBL Amikacin Apraclonidine eye drops 0.5%; $19.77 Iopidine 1% 1 January March 2015 A qa25123 Page 12 of 17
13 Pack price Hospital Supply DV Limit Listing date Hospital Supply Status date 5 ml, bottle Ciprofloxacin with hydrocortisone ear drops ciprofloxacin 0.2% with 1% hydrocortisone; 10 ml, bottle $16.30 Ciproxin HC Otic 1% 1 January March 2015 Dexamethasone with tobramycin eye drops 0.1% with tobramycin 0.3%; 5 ml, dropper bottle $12.64 Tobradex 1% 1 January March 2015 Dexmedetomidine Inj 100 mcg per ml, 2 ml vial, 5 vials $ Precedex Hydrocortisone with wool fat and mineral oil lotn 1% with wool fat hydrous 3% and mineral oil; 250 ml, bottle $10.57 DP Lotn HC 1% 1 October December 2014 Lidocaine [lignocaine] with adrenaline and tetracaine soln 4% with adrenaline 0.1 % and tetracaine 0.5%, 5 ml syringe; 1 syringe $17.50 Topicaine (Biomed) Mefloquine tab 250 mg; 8 tablet, blister pack $33.48 Lariam (Roche) 1% 1 October December 2014 Mepivacaine inj 3%, 1.8 ml dental cartridge; 50 dental cartridges $43.60 Scandonest 3% (Ivoclar) Mepivacaine inj 3%, 2.2 ml dental cartridge; 50 dental cartridges $43.60 Scandonest 3% (Ivoclar) Miconazole nitrate vaginal crm 2% with applicator; 40 g, tube $3.95 Micreme Nicotinic acid tab 50 mg; 100 tablet, blister pack $3.96 Apo-Nicotinic Acid Nicotinic acid tab 500 mg; 100 tablet, blister pack $17.37 Apo-Nicotinic Acid A qa25123 Page 13 of 17
14 Pack price Hospital Supply DV Limit Listing date Hospital Supply Status date Nitrazepam tab 5 mg; 100 tablet, bottle pack $5.22 Nitrados 1% 1 October December 2014 Oxazepam tab 10 mg; 100 tablet, blister pack $6.17 Ox-Pam 1% 1 October December 2014 Oxazepam tab 15 mg; 100 tablet, blister pack $8.53 Ox-Pam 1% 1 October December 2014 Pentamidine isethionate inj 300 mg vial; 5 vials $ Pentacarinat (Sanofi) 1% 1 January March 2015 *Rifaximin tab 550 mg; 56 tablet, blister pack $ Xifaxan (Norgine) Zidovudine [AZT] inj 10 mg per ml, 20 ml vial, 5 vials $ Retrovir IV (GSK) *Listing will be subject to Specialy Authority restrictions which will be outlined in the Pharmacetuical Schedule and a separate notification Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013: 2012/13 Invitation to Tender Tenoxicam Line Item Inj 20 mg 2013/14 Invitation to Tender Line Item Line Item Amikacin Inj 5 mg per ml, 5 ml Lidocaine [lignocaine] with adrenaline Inj 2% with adrenaline 1:200,000, 20 ml vial A qa25123 Page 14 of 17
15 Line Item Line Item Amikacin Amikacin Bupivacaine Bupivacaine Inj 5 mg per ml, 10 ml Inj 15 mg per ml, 5 ml Inj 1.25 mg per ml, 100 ml bag Inj 1.25 mg per ml, 200 ml bag Lidocaine [lignocaine] with adrenaline Lidocaine [lignocaine] with adrenaline Lidocaine [lignocaine] with adrenaline Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride Inj 2% with adrenaline 1:80,000, 1.7 ml dental cartridge Inj 2% with adrenaline 1:80,000, 1.8 ml dental cartridge Inj 2% with adrenaline 1:80,000, 2.2 ml dental cartridge Powder for oral soln g with potassium chloride 23.3 mg, sodium bicarbonate 89.3 mg and sodium chloride mg Bupivacaine Inj 1.25 mg per ml, 500ml bag Mebendazole Oral liq 100 mg per 5 ml Bupivacaine Inj 2.5 mg per ml, 200 ml bag Methotrexate Inj 100 mg per ml, 10 ml Calcium chloride with magnesium chloride, potassium chloride, sodium acetate, sodium chloride and sodium citrate Calcium chloride with magnesium chloride, potassium chloride, sodium acetate, sodium chloride and sodium citrate Calcium chloride with magnesium chloride, potassium chloride, sodium acetate, sodium chloride and sodium citrate Eye drops 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium acetate 0.17%, 15 ml Eye drops 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium acetate 0.17%, 250 ml Eye drops 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium acetate 0.17%, 500 ml Mitozantrone - Oxycodone Inj 2 mg per ml, 5 ml Inj 2 mg per ml, 30 ml syringe Inj 1 mg per ml, 100 ml bag Cefotaxime Inj 500 mg Pregabalin Cap 25 mg Celecoxib Cap 400 mg Pregabalin Cap 50 mg Chloramphenicol Ear drops 0.5% Pregabalin Cap 75 mg Chloramphenicol Eye drops 0.5%, single dose Pregabalin Cap 100 mg Chloramphenicol Inj 1 g Pregabalin Cap 150 mg A qa25123 Page 15 of 17
16 Line Item Line Item Docusate sodium Ear drops 0.5% Pregabalin Cap 200 mg Duloxetine Cap 30 mg Pregabalin Cap 225 mg Duloxetine Cap 60 mg Pregabalin Cap 300mg Emtricitabine Cap 200 mg Pregabalin Cap 25 mg Ephedrine Inj 3 mg per ml, 10 ml prefilled syringe Pregabalin Cap 50 mg Esomeprazole Tab 20 mg Propofol Inj 10 mg per ml, 50 ml syringe Esomeprazole Etoricoxib Etoposide phosphate Fluorouracil sodium Folic Acid Glucose [Dextrose] Granisetron Tab 40 mg Tab 30 mg Inj 100 mg (of etoposide base) Inj 25 mg per ml, 100 ml Tab 5 mg Inj 50%, 50 ml Inj 1 mg Sildenafil Sildenafil Sildenafil Sildenafil Sildenafil Sildenafil Sodium hyaluronate with chondroitin sulphate [current access] - Tab 25 mg [current access] - Tab 50 mg [current] - Tab 100 mg [widened access] - Tab 25 mg [widened access] - Tab 50 mg [widened access] - Tab 100 mg Inj 10 mg per ml, 0.5 ml; and inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.55 ml Hydrogen peroxide 3% (10 vol) Tobramycin Inj 100mg per ml, 5ml vial Hydrogen peroxide Crm 1% Inj 10 mg per ml, 100 ml bag Ibuprofen Tab long-acting 800 mg Zinc Paste, compound BP Ketoconazole Tab 200 mg Zopiclone Lidocaine [lignocaine] with adrenaline Lidocaine [lignocaine] with adrenaline Inj 1% with adrenaline 1:100,000, 5 ml ampoule Inj 1% with adrenaline 1:200,000, 20 ml vial Zopiclone Tab 7.5 mg (pack size greater than 30 Tab 7.5 mg (pack size of 30 or less) A qa25123 Page 16 of 17
17 PHARMAC has resolved not to award tenders for Sole Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 07 November 2013: Line Item Line Item Apraclonidine Eye drops 0.5% Dexamethasone with tobramycin Eye drops 0.1% with tobramycin 0.3% Hydrocortisone with ciprofloxacin Zidovudine [AZT] Ear drops 1% with ciprofloxacin 0.2% Inj 10 mg per ml, 20 ml vial PHARMAC has resolved not to award tenders for Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 07 November 2013: Line Item Glycerol Liquid BP For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on A qa25123 Page 17 of 17
Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Management Agency Pharmaceuticals Update Update effective 1 August 2014 New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014
30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 April 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, d 3 November
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014
31 October 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
31 August 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, d 6 November
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014
19 December 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
More information2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow)
31 March 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Status for some of the products included in the
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014
30 April 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
29 February 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2014/15 Invitation to Tender, d 6 November 2014, and
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and
More informationRelease of the 2013/14 Invitation to Tender
07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive
More informationRelease of the 2017/18 Invitation to Tender
2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s
More informationYour DISPENSARY Tips as at 26 November 2015
This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates
More informationPrice Changes advised by Pharmac As at 12 June 2015
s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule % + or - 01 Jun 15 31 Oct
More informationYour DISPENSARY Tips as at 11 March 2016
This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates
More informationPharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018
Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 August 2018 Contents Summary of decisions effective 1 August 2018... 3 Section H changes to Part II... 8 Index...
More informationApproval of proposals for various pharmaceuticals
9 August 2010 Approval of proposals for various pharmaceuticals PHARMAC is pleased to announce the approval of proposals for pharmaceuticals in several therapeutic groups which aim to address some issues
More informationRelease of the 2014/15 Invitation to Tender
6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until
More informationPrice Changes advised by Pharmac As at 02 July 2015
s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule 01 Jul 15 29 May 15 Irinotecan
More informationSection H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 May 2014 New Zealand Cumulative for April and May 2014 Pharmaceutical
More informationJuly 2017 Section H of the Pharmaceutical Schedule Update
16 June 2017 July 2017 Section H of the Pharmaceutical Schedule Update The Section H Update summary is provided to DHB hospital pharmacists as a preview of the changes that will be announced in the next
More informationPharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 December 2018
Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 December 2018 Contents Summary of decisions effective 1 December 2018... 3 Section H changes to Part II... 4 Index...
More informationApproval of Multiple Diabetes Management Products and Mesalazine proposals
8 June Approval of Multiple Diabetes Management Products and Mesalazine proposals PHARMAC is pleased to announce the approval of five agreements in relation to funding of blood glucose, blood glucose diagnostic
More informationSection H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 June 2014 New Zealand Cumulative for April, May and June 2014 Pharmaceutical
More informationANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2014 Cumulative for May, June, July, and August 2014 Contents Summary of PHARMAC decisions effective 1 August
More informationSupply should only occur if requesting signature is on approved list held by the issuing pharmacy
Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the
More informationRajasthan Medical Services Corporation Limited, Jaipur
Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV
More informationTo: Medical Groups, DHB Hospital Pharmacies and Interested Parties
24 September 2008 To: Medical Groups, DHB Hospital Pharmacies and Interested Parties CONSULTATION ON TENDER OF CERTAIN PHARMACEUTICALS ALL RESPONSES DUE BY 5PM, WEDNESDAY 5 NOVEMBER 2008 In accordance
More informationTable updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationTable updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product
More informationLIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.
LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml
More informationNIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
More informationUPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:
1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
More informationDATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:
UHS FC: 8703417 Dr. Marilyn Reaño 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic 120 btl 70.00 8,400.00 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic 240 btl 70.00 16,800.00
More informationAdvance Notification of Amendments to the March 2017 Drug Tariff
Advance Notification of Amendments to the March 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations Special Container Drug Qty Price Acetylcysteine 600mg capsules 30 39.95 A Caffeine citrate 50mg/5ml
More information(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59
Sole Supply - Pending Changes Quick Reference 1 *** Sorted by Sole *** Chemical Type, Strength, Pack Size Pharmacode Current New Tender of New of Sole Supply and Reference Start Thiamine hydrochloride
More informationOffice of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS
Acetaminophen 80mg/0.8mL Suspension Drops Acetaminophen 120mg Suppository Acetaminophen 160mg/5mL Suspension Acetaminophen 325mg Suppository Acetaminophen 325mg Tablet, Caplet, or Capsule Acetaminophen
More informationProposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe
26 April 2010 Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe PHARMAC is seeking feedback on the following proposals relating to the cholesterol lowering pharmaceuticals
More informationDry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.
Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole
More informationProvisional L1 rate of Non SSI and SSI tenderers for the Veterinary drugs for the year
Provisional L1 rate of and tenderers for the Veterinary drugs for the year 2011-12 Sl. Name of the 1 A3 Rabies Veterinary Vaccine Inactivated I.P. Single Dose with Syringe 25.87 Brilliant Biopharma 2 D4
More informationOFFERâ S INJECTABLES
A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 4 What s changing?... 6 Metoprolol succinate
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2015 Cumulative for May, June and July 2015 Contents Summary of PHARMAC decisions effective 1 July 2015... 3
More informationREQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY
16 October 2013 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY PHARMAC invites proposals for the supply of nicotine replacement therapy (including, but not limited to, nicotine
More informationREQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY
9 November 2016 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY PHARMAC invites proposals for the supply of nicotine replacement therapy (NRT) (including, but not limited to,
More informationCustomer Service: Shop online at
Effective May 1, 2017 Item Number Changes for Pharmaceuticals Due to changes in regulatory requirements, effective May 1, 2017, some of our pharmaceuticals' units of sale will change. The table below outlines
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2014 Cumulative for September and October 2014 Contents Summary of PHARMAC decisions effective 1 October
More informationKern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
More informationSection H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 November 2014
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update effective 1 November 2014 Update New Cumulative Zealand for August, September, October and
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2015 Cumulative for September and October 2015 Contents Summary of PHARMAC decisions effective 1 October
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 September 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2016 Contents Summary of PHARMAC decisions effective 1 September 2016... 3 What s changing?... 5 Pembrolizumab
More informationAdvance Notification of Amendments to the August 2018 Drug Tariff
Advance Notification of Amendments to the August 2018 Drug Tariff ADDITIONS Zero Discount Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 75mg tablets Maraviroc
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Diabetes Nurses Prescribers... 4 Tacrolimus brand
More informationAll Pharmacy Providers and Prescribing Practitioners. Subject: Updated and Revised Over-the-Counter Drug Formulary
Indiana Health Coverage Pros P R O V I D E R B U L L E T I N B T 2 0 0 3 5 8 A U G U S T 2 8, 2 0 0 3 To: All Pharmacy Providers and Prescribing Practitioners Subject: Overview Note: The information referenced
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2013 Cumulative for September and October 2013 Contents Summary of PHARMAC decisions effective 1 October
More informationUpper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)
Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET
More informationPRODUCT LIST GENERAL - TABLETS
SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 September 2017
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2017 Contents Summary of PHARMAC decisions effective 1 September 2017... 3 New listings... 5 Temozolomide
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March Section H cumulative for December 2011, January, February and March
More information10 Musculoskeletal and Joint Diseases
10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2012 Cumulative for September, October and November 2012 Section H cumulative for August, September, October
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2013 Contents Summary of PHARMAC decisions effective 1 September 2013... 3 New brand of enalapril maleate
More informationSection H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update Effective 1 November 2013 New Zealand Cumulative for July, August, September, October
More informationAdvance Notification of Amendments to the December 2018 Drug Tariff
Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016 Contents Summary of PHARMAC decisions
More informationAdministration and Supply of Emergency Medicines
APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule
More information500 Tablet 10,s Rs do- Each Tablet contains:- Levofloxacin as
Product List S.No# Reg.No Name of Drug(s)& composition Packing M R P Tablet Section Approved Shelf Life 1 072298 Wevofloxin-250 Tablet 10,s Rs.250.00 Two Years Levofloxacin as Hemihydrate 250mg (Manufacturer'
More information2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST
2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST Note: Prescriptions for OTCs must be written by a Denver Health provider and filled at a Denver Health Pharmacy Drug Name Strength Dosage Form 80mg-160mg,
More informationCritical Care Standard Infusion Concentrations
Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in
More informationPharmacy Providers and Prescribing Physicians. Updated Over-the-Counter Drug Formulary
P R O V I D E R B U L L E T I N BT200150 DECEMBER 12, 2001 To: Subject: Pharmacy Providers and Prescribing Physicians Note: The information in this bulletin is not directed to those providers rendering
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April Cumulative for January, February, March and April Contents Summary of PHARMAC decisions effective 1 April...
More informationProposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)
14 July 2015 Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) PHARMAC is seeking feedback on a proposal relating to the funding of the TNF-inhibitor medicines
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 May 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Sumatriptan update on Sumatriptan injections... 4
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March Contents Summary of PHARMAC decisions effective 1 March... 3 What
More informationPalliative Coverage Drug Benefit Supplement
Palliative Coverage Drug Benefit Supplement Effective April 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2013 Cumulative for September, October, November and December 2013 Contents Summary of PHARMAC decisions
More informationLIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope
LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2015 Cumulative for September, October and November 2015 Contents Summary of PHARMAC decisions effective
More information6 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu
PRODUCT MANUFACTURING LIST Tablet SECTIONS :- S.No. Composition Claim Pack Size Packing Type Remarks 1 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu 2 Each Film coated Tablet Contains
More informationADDITIONAL DRUG LISTING FOR MEDICARE & MEDI-CAL MEMBERS
MEDICARE & MEDICAL MEMBERS! Please read carefully! The following pages include additional drugs which may be covered for you with your doctor s prescription by MediCal (Medicaid). These drugs CANNOT be
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February Cumulative for January and February Contents Summary of PHARMAC decisions effective 1 February... 3 New
More informationRe: Important changes to Fortisip Powder
18 June 2014 Dear valued customer Nutricia Ltd 37 Banks Road, Mount Wellington Auckland, New Zealand PO Box 62 523 Greenlane, Auckland 1546 Tel: 0800 688 747 Re: Important changes to Fortisip Powder Nutricia
More information+91-8048718516 Proton Pharma Private Limited http://www.protonpharma.in/ We are one of the leading manufacturer and distributors of high quality Medicines. Owing to highest level of quality standards,
More informationAdvance Notification of Amendments to the April 2015 Drug Tariff
Advance Notification of Amendments to the April 2015 Drug Tariff ADDITIONS Part I - Drugs And Preparations Drug Qty Price Chlorambucil 2mg tablets 25 40.51 A Melphalan 2mg tablets 25 42.88 A Part III Appliances
More information17 October 2003 TO: PHARMACEUTICAL SUPPLIERS CONSULTATION ON TENDER OF CERTAIN PHARMACEUTICALS AND REQUESTS FOR PROPOSALS
Level 14, Cigna House, 17 October 2003 40 Mercer Street P O Box 10-254, Wellington NEW ZEALAND Phone 64 4 460 4990 Fax 64 4 460 4995 TO: PHARMACEUTICAL SUPPLIERS CONSULTATION ON TENDER OF CERTAIN PHARMACEUTICALS
More information2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST
2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST Note: Prescriptions for OTCs must be written by a Denver Health provider and filled at a Denver Health Pharmacy ACETAMINOPHEN ALCOHOL ANTISEPTIC PADS
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Abiraterone acetate (Zytiga) new listing... 5 Actavis
More informationDecision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)
9 September 2015 Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) The PHARMAC Board has approved the proposal relating to the funding of the TNF-inhibitor
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016 Contents Summary of PHARMAC decisions effective
More informationCare at the Chemist. Formulary
Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) For ages 2 years and over. Chloramphenicol 1% eye oint. (4g) For ages 2 years and over. Allergy Loratadine
More information1 ml) (100 x. 10 ml)
SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity
More information$55. today. Register. New Zealand Pharmaceutical Schedule. Effective 1 August www. schedule. co.nz. Sign up. Only
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2012 Cumulative for May, June, July and August 2012 Section H for August 2012 $55 Only annually for hard copy
More informationUmpqua Health Alliance (OHP) Formulary Changes January 2018
Umpqua Health Alliance (OHP) Formulary Changes January 2018 Umpqua Health Alliance would like to advise you of the following currently monthly changes that have been made to the Umpqua Health Alliance
More information